Q4 2024 Holdings
Filed 2025-02-14 | 52 holdings | $123.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $21.3M | 1,241,032 | 17.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $14.0M | 1,264,651 | 11.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $7.1M | 2,353,099 | 5.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $5.5M | 200,000 | 4.4% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $5.0M | 597,700 | 4.0% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $4.5M | 870,000 | 3.6% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.0M | 220,000 | 3.3% |
| Optinose Inc(0OP) | COM NEW | 68404V209 | $3.9M | 588,657 | 3.2% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $3.9M | 238,222 | 3.2% |
| Indivior PLC(INDV) | ORD | G4766E116 | $3.8M | 305,000 | 3.1% |
| Establishment Labs Holdings(ESTA) | COM | G31249108 | $3.7M | 80,002 | 3.0% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $3.7M | 1,132,388 | 3.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $3.5M | 324,324 | 2.8% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $3.3M | 125,700 | 2.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $3.0M | 235,000 | 2.4% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $2.9M | 648,785 | 2.3% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $2.4M | 683,530 | 2.0% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $2.0M | 137,200 | 1.6% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $1.9M | 1,050,000 | 1.6% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.9M | 331,900 | 1.5% |
| Myomo Inc(MYO) | COM NEW | 62857J201 | $1.8M | 274,426 | 1.4% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $1.7M | 468,793 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.6M | 663,405 | 1.3% |
| Profound Medical Corp(PROF) | COM NEW | 74319B502 | $1.5M | 200,000 | 1.2% |
| Jazz Pharmaceuticals PLC US Listed(JAZZ) | SHS USD | G50871105 | $1.2M | 10,000 | 1.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $1.2M | 164,106 | 1.0% |
| Milestone Pharmaceuticals in(MIST) | COM NEW | 59935V107 | $1.2M | 500,000 | 1.0% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $1.1M | 20,400 | 0.9% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $1.1M | 700,000 | 0.9% |
| Exagen Inc(XGN) | COM | 30068X103 | $1.0M | 251,049 | 0.8% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $882.0K | 300,000 | 0.7% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $844.8K | 110,000 | 0.7% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $809.1K | 535,805 | 0.7% |
| Kezar Life Sciences Inc(KZR) | COM | 49372L209 | $739.2K | 110,000 | 0.6% |
| Aytu Biopharma Inc(AYTU) | COM | 054754858 | $692.8K | 407,549 | 0.6% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $673.4K | 700,000 | 0.5% |
| Kiora Pharmaceuticals Inc(KPRX) | COM | 49721T507 | $663.2K | 200,970 | 0.5% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $618.1K | 182,317 | 0.5% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $569.6K | 160,000 | 0.5% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $490.9K | 149,221 | 0.4% |
| Acelyrin Inc | COM | 00445A100 | $417.2K | 132,870 | 0.3% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $345.0K | 250,000 | 0.3% |
| Polypid LTD(PYPD) | COM | M8001Q126 | $315.2K | 103,668 | 0.3% |
| Hillevax Inc | COM | 43157M102 | $274.0K | 132,347 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $271.5K | 196,732 | 0.2% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $119.8K | 25,000 | 0.1% |
| Elevation Oncology Inc | COM | 28623U101 | $112.5K | 200,000 | 0.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $109.8K | 15,000 | 0.1% |
| Alimera Sciences Inc CVR | COM | 016CVR029 | $107.1K | 2,408,469 | 0.1% |
| Allarity Therapeutics Inc(ALLR) | COM | 016744500 | $78.7K | 67,289 | 0.1% |